Literature DB >> 34118400

Cardiac pathology and outcomes vary between Kawasaki disease and PIMS-TS.

Susanna Felsenstein1, Phuoc Duong2, Steven Lane3, Caroline Jones2, Clare E Pain4, Christian M Hedrich5.   

Abstract

Overlapping clinical features promoted the discussion of whether Kawasaki disease (KD) and PIMS-TS share pathophysiological features and disease outcomes. Medical records from English patients with KD (2015-02/20, N = 27) and PIMS-TS (02/2020-21, N = 34) were accessed to extract information. Children with PIMS-TS were older and more frequently of minority ethnicity background. They patients more commonly exhibited cytopenias and hyperferritinemia, which associated with diffuse cardiac involvement and functional impairment. In some PIMS-TS cases, cardiac pathology developed late, but outcomes were more favorable. In both, KD and PIMS-TS, baseline coronary diameter was a predictor of outcomes. PIMS-TS treatment more frequently included respiratory and cardiovascular support, and corticosteroids with IVIG. Cardiac involvement in PIMS-TS may be the result of a cytokine storm. Though more severe and diffuse when compared to KD, cardiac involvement of PIMS-TS has a more favorable prognosis, which may, after recovery, mitigate the need for long-term follow up.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COVID; KD; Kawasaki; MIS-C; Outcome; PIMS-TS; Pediatric; Treatment

Year:  2021        PMID: 34118400     DOI: 10.1016/j.clim.2021.108780

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  3 in total

1.  Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022) : Updated statement of the Austrian Society of Pneumology (ASP).

Authors:  Horst Olschewski; Ernst Eber; Brigitte Bucher; Klaus Hackner; Sabin Handzhiev; Konrad Hoetzenecker; Marco Idzko; Walter Klepetko; Gabor Kovacs; Bernd Lamprecht; Judith Löffler-Ragg; Michael Meilinger; Alexander Müller; Christian Prior; Otmar Schindler; Helmut Täubl; Angela Zacharasiewicz; Ralf Harun Zwick; Britt-Madelaine Arns; Josef Bolitschek; Katharina Cima; Elisabeth Gingrich; Maximilian Hochmair; Fritz Horak; Peter Jaksch; Roland Kropfmüller; Andreas Pfleger; Bernhard Puchner; Christoph Puelacher; Patricia Rodriguez; Helmut J F Salzer; Peter Schenk; Ingrid Stelzmüller; Volker Strenger; Matthias Urban; Marlies Wagner; Franz Wimberger; Holger Flick
Journal:  Wien Klin Wochenschr       Date:  2022-04-21       Impact factor: 2.275

Review 2.  The immunopathogenesis of SARS-CoV-2 infection in children: diagnostics, treatment and prevention.

Authors:  Harsita Patel; Andrew McArdle; Eleanor Seaby; Michael Levin; Elizabeth Whittaker
Journal:  Clin Transl Immunology       Date:  2022-07-25

3.  SARS-CoV-2 variants and the risk of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 among children in Germany.

Authors:  A L Sorg; V Schönfeld; A Siedler; M Hufnagel; M Doenhardt; N Diffloth; R Berner; R V Kries; J Armann
Journal:  Infection       Date:  2022-09-01       Impact factor: 7.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.